Skip to main content

Merck reports positive results for blockbuster cancer drug in treating non-small cell lung cancer

Keytruda showed a 'statistically significant and clinically meaningful improvement' in overall survival in a late-stage trial.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.